Are you looking for a safe, customized approach to healing chronic or complex conditions? At DriipIV Nutrient Therapy, we offer TruDOSE Regenerative Technology, a precision-based therapy that supports your body’s natural ability to heal using your own biology.
At DriipIV Nutrient Therapy, we focus on identifying and addressing the root causes of chronic illness. TruDOSE Regenerative Technology™ allows us to deliver a personalized dose of your own blood platelets, helping your body repair and recover from the inside out.
We offer support for a wide range of conditions, including:
PANS / PANDAS
Lyme
Autism
Autoimmune
Neurological
Chronic Illness
General Wellness
Parkinson’s
Chronic Fatigue Syndrome / Myalgic Encephalomyelitis
“Long COVID” and Post-Viral Syndromes
Neurological & Cognitive Support
Every TruDOSE™ treatment is individualized based on your condition, goals, and overall health profile.
We take a functional medicine approach to healing by addressing the root causes of illness. We’re proud to offer TruDOSE™ personalized IV platelet therapy, a cutting-edge treatment designed to calm inflammation, support immune balance, and promote natural repair. Our mission is to help you restore energy, reduce pain, and thrive with long-term wellness.
TruDOSE Regenerative Technology™ is not a supplement or general PRP therapy. It is an advanced regenerative therapy that delivers a precisely calibrated dose of your body’s own platelets, based on your unique biological profile.
Each certified provider is trained in this technology to ensure that every treatment is customized, consistent, and guided by your specific health needs.
We are currently accepting new patients. If you’re ready to explore TruDOSE Regenerative Technology, fill out the short form below. A team member from DriipIV Nutrient Therapy will follow up with you as soon as possible.
DriipIV Nutrient Therapy is a certified provider offering advanced regenerative platelet therapy for conditions such as autoimmune disease, chronic inflammation, Lyme disease, long COVID, and more.